Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.38 USD | +3.51% | +2.23% | -26.31% |
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | 122M | 180M | 56.81M | 44.32M | 117M | ||
Total Revenues | 122M | 180M | 56.81M | 44.32M | 117M | ||
Cost of Goods Sold, Total | 50.6M | 73.91M | 20.78M | 15.1M | 42.12M | ||
Gross Profit | 71.22M | 106M | 36.03M | 29.22M | 75.31M | ||
Selling General & Admin Expenses, Total | 63.8M | 98.8M | 231M | 204M | 210M | ||
R&D Expenses | 57.17M | 105M | 137M | 135M | 167M | ||
Other Operating Expenses | -3.41M | -6.58M | -11.2M | -6.09M | -6.23M | ||
Other Operating Expenses, Total | 118M | 197M | 357M | 333M | 372M | ||
Operating Income | -46.34M | -91.3M | -321M | -304M | -296M | ||
Interest Expense, Total | -837K | -2.34M | -1.8M | -3.82M | -14.95M | ||
Interest And Investment Income | 883K | 3.8M | 5.14M | 4.67M | 8.48M | ||
Net Interest Expenses | 46K | 1.46M | 3.34M | 850K | -6.47M | ||
Income (Loss) On Equity Invest. | -74K | 236K | -276K | 196K | -1.56M | ||
Currency Exchange Gains (Loss) | 109K | -333K | -827K | -1.49M | 394K | ||
Other Non Operating Income (Expenses) | -976K | -1.9M | 4.54M | -21.59M | 1.89M | ||
EBT, Excl. Unusual Items | -47.24M | -91.84M | -314M | -326M | -302M | ||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | ||
Gain (Loss) On Sale Of Assets | - | - | - | 103K | -138K | ||
Legal Settlements | - | - | - | -3.38M | - | ||
EBT, Incl. Unusual Items | -47.24M | -91.84M | -314M | -329M | -302M | ||
Income Tax Expense | 754K | 206K | 134K | 79K | 206K | ||
Earnings From Continuing Operations | -47.99M | -92.04M | -314M | -329M | -302M | ||
Net Income to Company | -47.99M | -92.04M | -314M | -329M | -302M | ||
Minority Interest | -551K | 4.42M | -63K | 1.11M | 641K | ||
Net Income - (IS) | -48.54M | -87.62M | -314M | -328M | -302M | ||
Preferred Dividend and Other Adjustments | 27.25M | - | - | - | - | ||
Net Income to Common Incl Extra Items | -75.79M | -87.62M | -314M | -328M | -302M | ||
Net Income to Common Excl. Extra Items | -75.79M | -87.62M | -314M | -328M | -302M | ||
Per Share Items | |||||||
Net EPS - Basic | -2.48 | -1.6 | -5.56 | -5.72 | -4.97 | ||
Basic EPS - Continuing Operations | -2.48 | -1.6 | -5.56 | -5.72 | -4.97 | ||
Basic Weighted Average Shares Outstanding | 30.57M | 54.78M | 56.49M | 57.35M | 60.75M | ||
Net EPS - Diluted | -2.48 | -1.6 | -5.56 | -5.72 | -4.97 | ||
Diluted EPS - Continuing Operations | -2.48 | -1.6 | -5.56 | -5.72 | -4.97 | ||
Diluted Weighted Average Shares Outstanding | 30.57M | 54.78M | 56.49M | 57.35M | 60.75M | ||
Normalized Basic EPS | -0.98 | -0.97 | -3.47 | -3.53 | -3.1 | ||
Normalized Diluted EPS | -0.98 | -0.97 | -3.47 | -3.53 | -3.1 | ||
American Depositary Receipts Ratio (ADR) | 2 | 2 | 2 | 2 | 2 | ||
Supplemental Items | |||||||
EBITDA | -40.67M | -85.1M | -313M | -295M | -283M | ||
EBITA | -46.34M | -91.3M | -321M | -304M | -295M | ||
EBIT | -46.34M | -91.3M | -321M | -304M | -296M | ||
EBITDAR | -32.22M | -76.08M | -302M | -281M | -271M | ||
Total Revenues (As Reported) | 122M | 180M | 56.81M | 44.32M | 117M | ||
Effective Tax Rate - (Ratio) | -1.6 | -0.22 | -0.04 | -0.02 | -0.07 | ||
Total Current Taxes | 803K | 22K | 134K | 79K | 206K | ||
Total Deferred Taxes | -49K | 184K | - | - | - | ||
Normalized Net Income | -30.08M | -52.97M | -196M | -203M | -188M | ||
Supplemental Operating Expense Items | |||||||
Advertising Expense | 3.42M | 1.96M | 2.11M | 2.94M | 2.92M | ||
Selling and Marketing Expenses | 26.86M | 37.19M | 43.23M | 53.12M | 60.39M | ||
General and Administrative Expenses | 36.95M | 61.61M | 187M | 151M | 150M | ||
Research And Development Expense From Footnotes | 57.17M | 105M | 137M | 135M | 167M | ||
Net Rental Expense, Total | 8.46M | 9.02M | 10.46M | 14.29M | 11.7M | ||
Imputed Operating Lease Interest Expense | 2.26M | 4.09M | 4.02M | 3.8M | 7.7M | ||
Imputed Operating Lease Depreciation | 6.2M | 4.93M | 6.44M | 10.5M | 4M | ||
Stock-Based Comp., COGS (Total) | 365K | 2.44M | - | - | - | ||
Stock-Based Comp., R&D Exp. (Total) | 5.12M | 27.08M | 31.66M | 36.32M | 53.2M | ||
Stock-Based Comp., S&M Exp. (Total) | 743K | 10.88M | 18.33M | 22.12M | 18.96M | ||
Stock-Based Comp., G&A Exp. (Total) | 8.52M | 14.45M | 71.15M | 38.45M | 79.33M | ||
Total Stock-Based Compensation | 14.75M | 54.86M | 121M | 96.9M | 151M |